Excellent outcomes in children and adolescents with CNS⁺ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

Affiliations

• ¹ Paediatric Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
• ² Paediatric Hematology-Oncology, Mayo Clinic, Rochester, MN, USA.
• ³ Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
• ⁴ Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France.
• ⁵ Frontier Science and Technology Research Foundation, Madison, WI, USA.
• ⁶ University of Queensland, Brisbane, Queensland, Australia.
• ⁷ Children's Oncology Group, Monrovia, CA, USA.
• ⁸ Center for Global Health, National Cancer Institute, National Institute of Health, Rockville, MD, USA.
• ⁹ Paediatric Oncology Adolescent and Young Adult Department, Institut Curie, Paris, France.
• ¹⁰ Paediatric Haematology and Oncology Unit, AP-HP, Armand Trousseau Hospital, UPMC Univ Paris 06, Paris, France.
• ¹¹ Paediatric Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
• ¹² Paediatrics, New York Medical College, Valhalla, NY, USA.
• ¹³ Paediatric Hematology-Oncology, University of Hawaii, Honolulu, HI, USA.
• ¹⁴ Paediatrics, Roswell Park Cancer Institute, Buffalo, NY, USA.
• ¹⁵ Paediatric Hematology-Oncology, Medical City Children's Hospital, Dallas, TX, USA.
• ¹⁶ Department of Cancerology for Children and Adolescents, Gustave Roussy, Villejuif, France.
• ¹⁷ Medicine, Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA.